Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis

OBJECTIVE: Macrophage activation syndrome (MAS) is a life-threatening, potentially fatal condition associated with systemic juvenile idiopathic arthritis (sJIA). Interleukin-1 (IL-1) is a key cytokine in the pathogenesis of sJIA MAS. Many cases of MAS are medically refractory to traditional doses of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostik, Mikhail M., Isupova, Eugenia A., Belozerov, Konstantin, Likhacheva, Tatyana S., Suspitsin, Evgeny N., Raupov, Rinat, Masalova, Vera V., Chikova, Irina A., Dubko, Margarita F., Kalashnikova, Olga V., Chasnyk, Vyacheslav G., Cron, Randy Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366524/
https://www.ncbi.nlm.nih.gov/pubmed/35967555
http://dx.doi.org/10.3389/fped.2022.894846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366524/
https://www.ncbi.nlm.nih.gov/pubmed/35967555
http://dx.doi.org/10.3389/fped.2022.894846

Ejemplares similares